Threat to breast cancer testing after controversial patent ruling

Warning that American company's victory could make procedure more expensive

Testing for breast cancer could become more difficult and expensive to carry out following a controversial ruling by the European Patent Office that has given an American company rights over a key test for breast cancer.

In a long-running dispute over a test based on the breast cancer gene BRCA1, the European Patent Office ruled in favour of giving Myriad Genetics intellectual property rights over its test for some of the genetic mutations that can lead to breast cancer.

Although the ruling has not given Myriad all the rights it originally applied for, senior clinical geneticists believe that the decision may allow the company to claim royalties for tests developed by other scientists – and as a result lead to fewer tests.

"The fact is these tests are being done and I would very much regret it if they stopped because Myriad put cease-and-desist orders on them. They could do that. We've always been looking over our shoulders to see if Myriad is coming," said Dr Rob Elles, chairman of the British Society for Human Genetics.

About 13 per cent of women develop breast cancer but if they have inherited a faulty version of the BRCA1 gene their risk can jump to 85 per cent.

If women test positive for a BRCA1 mutation they can be offered prophylactic surgery to remove the breast tissue that is at risk A negative result usually means they have a normal risk of breast cancer.

The patent office's ruling has given Myriad rights over two mutations that are frequently detected in Ashkenazi Jews, which means that any genetics centre that uses the BRCA1 test – even if it developed its own test – will have to take this into consideration.

Professor Gert Matthijs, a human geneticist at the University of Leuven in Belgium, said that the ruling means that Myriad could in principle claim infringement of its patent even if a doctor is merely trying to find out what sort of BRCA1 mutation a woman has inherited. He said the issuing of the BRCA1 gene patent to Myriad in 2001 led to a monopoly that was bad for medicine because it dissuaded other companies from developing rival tests.

A spokesman for Myriad Genetics said: "It is important for us to point out that research activities with the patented technologies are not limited in any way by Myriad and are encouraged through subsidised costs for testing from the company to researchers."

Sarah Rawlings, head of policy at Breakthrough Breast Cancer, said she hoped the patent decision would not negatively impact on genetic testing services currently available in the UK.

Life and Style
ebookNow available in paperback
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Web Developer - Junior / Middleweight

    Negotiable: Recruitment Genius: One of the South East's fastest growing full s...

    Guru Careers: Marketing Manager / Marketing Communications Manager

    £35-40k (DOE) + Benefits: Guru Careers: We are seeking a Marketing Communicati...

    Recruitment Genius: Commercial Engineer

    £30000 - £32000 per annum: Recruitment Genius: Estimating, preparation of tech...

    Recruitment Genius: IT Support Technician

    £14000 - £17000 per annum: Recruitment Genius: You will work as part of a smal...

    Day In a Page

    Blundering Tony Blair quits as Middle East peace envoy – only Israel will miss him

    Blundering Blair quits as Middle East peace envoy – only Israel will miss him

    For Arabs – and for Britons who lost their loved ones in his shambolic war in Iraq – his appointment was an insult, says Robert Fisk
    Fifa corruption arrests: All hail the Feds for riding to football's rescue

    Fifa corruption arrests

    All hail the Feds for riding to football's rescue, says Ian Herbert
    Isis in Syria: The Kurdish enclave still resisting the tyranny of President Assad and militant fighters

    The Kurdish enclave still resisting the tyranny of Assad and Isis

    In Syrian Kurdish cantons along the Turkish border, the progressive aims of the 2011 uprising are being enacted despite the war. Patrick Cockburn returns to Amuda
    How I survived Cambodia's Killing Fields: Acclaimed surgeon SreyRam Kuy celebrates her mother's determination to escape the US

    How I survived Cambodia's Killing Fields

    Acclaimed surgeon SreyRam Kuy celebrates her mother's determination to escape to the US
    Stephen Mangan interview: From posh buffoon to pregnant dad, the actor has quite a range

    How Stephen Mangan got his range

    Posh buffoon, hapless writer, pregnant dad - Mangan is certainly a versatile actor
    The ZX Spectrum has been crowd-funded back into play - with some 21st-century tweaks

    The ZX Spectrum is back

    The ZX Spectrum was the original - and for some players, still the best. David Crookes meets the fans who've kept the games' flames lit
    Grace of Monaco film panned: even the screenwriter pours scorn on biopic starring Nicole Kidman

    Even the screenwriter pours scorn on Grace of Monaco biopic

    The critics had a field day after last year's premiere, but the savaging goes on
    Menstrual Hygiene Day: The strange ideas people used to believe about periods

    Menstrual Hygiene Day: The strange ideas people once had about periods

    If one was missed, vomiting blood was seen as a viable alternative
    The best work perks: From free travel cards to making dreams come true (really)

    The quirks of work perks

    From free travel cards to making dreams come true (really)
    Is bridge the latest twee pastime to get hip?

    Is bridge becoming hip?

    The number of young players has trebled in the past year. Gillian Orr discovers if this old game has new tricks
    Long author-lists on research papers are threatening the academic work system

    The rise of 'hyperauthorship'

    Now that academic papers are written by thousands (yes, thousands) of contributors, it's getting hard to tell workers from shirkers
    The rise of Lego Clubs: How toys are helping children struggling with social interaction to build better relationships

    The rise of Lego Clubs

    How toys are helping children struggling with social interaction to build better relationships
    5 best running glasses

    On your marks: 5 best running glasses

    Whether you’re pounding pavements, parks or hill passes, keep your eyes protected in all weathers
    Joe Root: 'Ben Stokes gives everything – he’s rubbing off on us all'

    'Ben Stokes gives everything – he’s rubbing off on us all'

    Joe Root says the England dressing room is a happy place again – and Stokes is the catalyst
    Raif Badawi: Wife pleads for fresh EU help as Saudi blogger's health worsens

    Please save my husband

    As the health of blogger Raif Badawi worsens in prison, his wife urges EU governments to put pressure on the Saudi Arabian royal family to allow her husband to join his family in Canada